Tuesday, September 11, 2018

DWI-MRI Acquired 12 Weeks After Start Of Neoadjuvant Chemotherapy For Breast Cancer May Offer Best Indication Of How Patients Will Respond To Treatment, Study Suggests.

Aunt Minnie (9/11, Forrest) reports that research suggests “diffusion-weighted MR images (DWI-MRI) acquired 12 weeks after the start of neoadjuvant chemotherapy for breast cancer may provide the best indication of how patients will respond to treatment.” The findings from the “study, known as the American College of Radiology Imaging Network (ACRIN) 6698 trial,” were published online in Radiology.

Author: Nicole Hardy

Categories: 2018, September, News, Screening and MammographyNumber of views: 1539


Theme picker